Author:
Doherty Jennifer,Bonadies Danielle C.,Matloff Ellen T.
Reference22 articles.
1. Ambry Genetics. (2014). BRCAplus: A 6-gene hereditary breast cancer test. White Paper. http://www.ambrygen.com/sites/default/files/pdfs/forms/most_updated/cancer/BRCAPlus_While %20_Paper_0214.pdf. Accessed on June 11, 2014.
2. Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., & Easton, D. F. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics, 72(5), 1117–1130. doi: 10.1086/375033 .
3. Arpino, G., Bardou, V. J., Clark, G. M., & Elledge, R. M. (2004). Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Research, 6(3), R149–R156. doi: 10.1186/bcr767 .
4. Association for Molecular Pathology v. Myriad Genetics, Inc., et al. (2013). 12–398.
5. Benusiglio, P. R., Malka, D., Rouleau, E., De Pauw, A., Buecher, B., Nogues, C., & Caron, O. (2013). CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. Journal of Medical Genetics, 50(7), 486–489. doi: 10.1136/jmedgenet-2012-101472 .